Phys Vivas · respiratory
Respiratory Investigation — Viva Defence
Structured DCE viva for respiratory investigation: defending the investigation chain in progressive dyspnoea with crackles — HRCT, pulmonary function tests, and the BAL/biopsy decision in suspected interstitial lung disease.
On this page & tools
Target exams
Opening statement (SASPOP, delivered aloud)
"Mrs Marsh is a 63-year-old never-smoker with 14 months of progressive exertional dyspnoea, dry cough, Velcro crackles and early clubbing — a presentation I would frame as suspected fibrotic interstitial lung disease until proven otherwise. My problems are: first, confirming and staging the physiological severity of what is likely a restrictive, gas-transfer-impaired lung disease; second, establishing the radiological and, if needed, histological pattern, because pattern determines treatment; third, hunting an underlying cause — connective tissue disease, drug or exposure-related; and fourth, doing all of this through the least invasive sequence that still answers each question. I would like to begin with full pulmonary function tests and an HRCT, then bring her to a multidisciplinary discussion before any tissue diagnosis is considered." [1]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Physician Medicine fellowship atlas.
References4Show ledgerHide ledger
- [1]Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests Eur Respir J, 2022.PMID 34949706
- [2]Graham BL, Brusasco V, Burgos F, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung Eur Respir J, 2017.PMID 28049168
- [3]Du Rand IA, Blaikley J, Booton R, et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE Thorax, 2013.PMID 23860341
- [4]von Bartheld MB, Dekkers OM, Szlubowski A, et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial JAMA, 2013.PMID 23780458